Clinical Trials Logo

Clinical Trial Summary

This is a follow-up study of a recently completed trial (17.14.INF) evaluating the growth of pre-term infants. Enrolled children will undergo neurocognitive assessments at 18- and 24-months of corrected age (CA).


Clinical Trial Description

This is a follow-up study of a recently completed multi-center, prospective, single-arm, open-label interventional trial (17.14.INF - Alprem RTF: NCT03728764) evaluating the growth of pre-term infants receiving a two-stage PTF feeding system while in the neonatal care unit and continuing until 30 days post-discharge. Enrolled children will undergo neurocognitive assessments at 18- and 24-months of corrected age (CA). The timing of the cognitive assessments aligns with routine check-up visits and reflect the period at which developmental delays may first become evident. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04962035
Study type Observational
Source Société des Produits Nestlé (SPN)
Contact
Status Completed
Phase
Start date March 26, 2021
Completion date December 22, 2021

See also
  Status Clinical Trial Phase
Recruiting NCT05527080 - Development of Motility and Cognition in Infants
Recruiting NCT02378246 - Swedish Iodine in Pregnancy and Development in Children (SWIDDICH) Study N/A
Recruiting NCT05201534 - Interventions in Mathematics and Cognitive Skills N/A
Completed NCT03612505 - Caregiver Interventions for Developmental Delays in Young Kenyan Children N/A
Completed NCT04345185 - Effects of Infant Egg Consumption on Child Health and Cognition Development
Completed NCT04252807 - A Common Elements-based Intervention to Improve Maternal Psychological Well-being and Mother-infant Interaction N/A
Completed NCT03552341 - Iodine Status in Pregnancy and Associated Health Outcomes
Completed NCT05217056 - Associations Between General Movements Assessments and Cognitive Development